— Ticker · NMS —
AMGN · Amgen Inc.
Healthcare · Drug Manufacturers - General
AMGN
$377.06
▼ -15.10%
7-day move
7-day move
day$375.80 → $381.0452-wk$269.77 → $447.03avg vol2.7M / 3Mcap$203.9B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 15.5 |
| P/E (trailing) | 23.4 |
| EPS (forward) | $24.40 |
| EPS (trailing) | $16.11 |
| PEG | 2.30 |
| Dividend | 2.64% |
The Risk
| Beta | 0.43 |
| Short % float | 2.40% |
| Float | 539.2M |
| Shares out | 540.6M |
| Avg vol (3M) | 2.7M |
| 52w range | $269.77 → $447.03 |
The Analyst Tape
strong buybuyholdunderperformsell
$388.03
avg 12-mo target
+2.9%
vs. last · 29 analysts
At a Glance
$203.9B
market cap (USD)
exchangeNMS
sectorHealthcare
industryDrug Manufacturers - General
market cap$203.9B
websiteamgen.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for AMGN in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for AMGN.
Indicators That Mention AMGN
8 of our 658 catalog map to AMGN
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Healthcare · by market cap · 7-day move
— Voices on AMGN —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning AMGN. Opinion, not wire.
No recent commentary mentioning AMGN in the last 7 days.
Analyst · previewYou're seeing the public read on AMGN. Analyst unlocks every pundit call on AMGN with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with AMGN as the target + the API / MCP feed.Compare tiers →